文献速递腹部MR

鉴别局灶性结节性增生与肝细胞腺瘤:使用线性钆对比剂的肝胆期MRI(HBP-MRI)总是有用吗?

Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

回顾性纳入49例患者共119个病灶(90个局灶性结节性增生、29个肝细胞腺瘤),比较常规MRI与联合肝胆期MRI对两者的鉴别效能。肝胆期MRI使敏感度(38.9% vs 97.8%)、总准确率(53.8% vs 98.3%)及观察者间一致性(Kappa 0.56 vs 0.88)显著提高,特异度不变(100%)。作者结论认为肝胆期MRI的临床影响主要在于小于3 cm的局灶性结节性增生。

要点

  • 肝胆期MRI将局灶性结节性增生诊断敏感度从38.9%提高到97.8%,总准确率从53.8%提高到98.3%。
  • 常规MRI对≤3 cm的局灶性结节性增生敏感度仅20%,联合肝胆期MRI后提高到88%。
  • 肝胆期上所有局灶性结节性增生均呈低信号,约97%的肝细胞腺瘤也呈低信号。

核心结论

  • 肝胆期MRI的临床影响主要在于小于3 cm的局灶性结节性增生,对较大病灶及肝细胞腺瘤诊断的价值有限,因为常规MRI对肝细胞腺瘤诊断已准确; upfront使用细胞外对比剂可限制线性肝胆期对比剂用于良性肝细胞病灶定性的需求。

研究设计与样本

  • 经IRB批准的回顾性研究,纳入49例因Gd-BOPTA增强MRI转诊的患者,共119个病灶(90个局灶性结节性增生,29个肝细胞腺瘤);两名观察者在两次随机阅片中分别评估联合肝胆期图像与不联合肝胆期图像的MRI表现,每个病灶按5分制评分(1代表典型局灶性结节性增生,5代表肯定不是局灶性结节性增生)。

关键影像表现/征象

  • 肝胆期上所有局灶性结节性增生均表现为相对于邻近肝实质的低信号。
  • 肝胆期上近97%的肝细胞腺瘤表现为低信号。

诊断标准与关键数值

  • 肝胆期MRI诊断局灶性结节性增生的敏感度为97.8%,常规MRI为38.9%。
  • 肝胆期MRI的总准确率为98.3%,常规MRI为53.8%。
  • 两种方法的特异度均为100%。
  • 肝胆期MRI的观察者间一致性Kappa为0.88,常规MRI为0.56。
  • 常规MRI对≤3 cm病灶诊断局灶性结节性增生的敏感度为20%,在联合肝胆期MRI的相应条件下为88%。

临床应用与阅片要点

  • 原文指出肝胆期MRI的临床影响主要在于小于3 cm的局灶性结节性增生,对较大局灶性结节性增生及肝细胞腺瘤诊断的价值较有限; upfront使用细胞外对比剂可限制线性肝胆期对比剂用于良性肝细胞病灶定性的需求。

局限性

  • 原文为回顾性研究。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the value of Hepatobiliary phase MRI (HPB-MRI) to differentiate FNH and HCA, and evaluate its impact on diagnostic accuracy, diagnostic confidence, inter-observer variability, and patient clinical management.

METHODS: Forty-nine patients referred for Gd-BOPTA-enhanced MRI were retrospectively included in this IRB-approved study, with a total of 119 lesions-90 FNH and 29 HCA. Two observers separately assessed in 2 distinct randomized reading sessions the performance of MRI with (HBP-MRI) or without (conventional MRI) the use of HBP images. Each lesion was ranked with a 5-point scale (from 1 Typical FNH to 5 Certainly not a FNH). Sensitivity, specificity, overall accuracy, and inter-observer agreement for the differentiation of FNH from HCA were calculated and compared between conventional and HBP-MRI.

RESULTS: Both sensitivity (respective values of 38.9% and 97.8%), overall accuracy (respective values of 53.8% and 98.3%), and inter-observer agreement (respective values of Kappa 0.56 and 0.88) were significantly higher using HBP-MRI than with conventional MRI, with unchanged specificity (100%). The sensitivity of conventional MRI for the diagnosis of FNH was significantly lower in lesions ≤ 3 cm (20% vs. 88%). Overall, HBP could have changed lesion management in 59/119 cases (49.5%), including 53 FNH and 6 HCA with no impact in 60/119 lesions (50.5%) including all 35 lesions classified as scores 1 and 2 for the diagnosis of FNH.

CONCLUSIONS: The clinical impact of HBP-MRI is mostly important for smaller than 3-cm FNH, and more limited in larger FNH lesions as well as for HCA diagnosis for which conventional MRI is already accurate. The use of extracellular contrast agents upfront could limit the required use of linear HBP contrast agents for benign hepatocellular lesion characterization. On HBP, all FNH appeared hypointense compared to adjacent liver while close to 97% of HCA appeared hypointense.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Roux M, Pigneur F, Baranes L, et al. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? Abdom Radiol (NY). 2018. PMID: 29110059. doi:10.1007/s00261-017-1377-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。